Your browser doesn't support javascript.
loading
Towards patient-led follow-up after curative surgical resection of stage I, II and III colorectal cancer (DISTANCE-trial): a study protocol for a stepped-wedge cluster-randomised trial.
Swartjes, Hidde; Qaderi, Seyed M; Teerenstra, Steven; Custers, Jose A E; Elferink, Marloes A G; van Wely, Bob J; Burger, Jacobus W A; van Grevenstein, Wilhelmina M U; van Duijvendijk, Peter; Verdaasdonk, Emiel G G; de Roos, Marnix A J; Coupé, Veerle M H; Vink, Geraldine R; Verhoef, Cornelis; de Wilt, Johannes H W.
Afiliación
  • Swartjes H; Department of Surgery, Radboud university medical center, 6500, Nijmegen, The Netherlands.
  • Qaderi SM; Department of Surgery, Radboud university medical center, 6500, Nijmegen, The Netherlands.
  • Teerenstra S; Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands.
  • Custers JAE; Department of Medical Psychology, Radboud university medical center, Nijmegen, The Netherlands.
  • Elferink MAG; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.
  • van Wely BJ; Department of Surgery, Ziekenhuis Bernhoven, Uden, The Netherlands.
  • Burger JWA; Department of Surgery Catharina Hospital, Eindhoven, The Netherlands.
  • van Grevenstein WMU; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • van Duijvendijk P; Department of Surgery, Gelre Hospitals, Apeldoorn, The Netherlands.
  • Verdaasdonk EGG; Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
  • de Roos MAJ; Department of Gastrointestinal Surgery and Surgical Oncology, Rijnstate Hospital, Arnhem, The Netherlands.
  • Coupé VMH; Department of Epidemiology and Data Science Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Verhoef C; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • de Wilt JHW; Department of Surgery, Radboud university medical center, 6500, Nijmegen, The Netherlands. hans.dewilt@radboudumc.nl.
BMC Cancer ; 23(1): 838, 2023 Sep 07.
Article en En | MEDLINE | ID: mdl-37679735
ABSTRACT

BACKGROUND:

Colorectal cancer (CRC) is among the most frequently diagnosed cancers. Approximately 20-30% of stage I-III CRC patients develop a recurrent tumour or metastases after curative surgical resection. Post-operative follow-up is indicated for the first five years after curative surgical resection. As intensified follow-up after curative surgical resection has shown no effect on survival, patient organisations and policy makers have advocated for a more patient-centred approach to follow-up. The objective of this study is to successfully implement patient-led, home-based follow-up (PHFU) in six hospitals in The Netherlands, with as ultimate aim to come to a recommendation for a patient-centred follow-up schedule for stage I-III CRC patients treated with surgical resection with curative intent.

METHODS:

This study is designed as a stepped-wedge cluster-randomised trial (SW-CRT) in six participating centres. During the trial, three centres will implement PHFU after six months; the other three centres will implement PHFU after 12 months of inclusion in the control group. Eligible patients are those with pT2-4N0M0 or pT1-4N1-2M0 CRC, who are 18 years or older and have been free of disease for 12 months after curative surgical resection. The studied intervention is PHFU, starting 12 months after curative resection. The in-hospital, standard-of-care follow-up currently implemented in the participating centres functions as the comparator. The proportion of patients who had contact with the hospital regarding CRC follow-up between 12-24 months after curative surgical resection is the primary endpoint of this study. Quality of life, fear of cancer recurrence, patient satisfaction, cost-effectiveness and survival are the secondary endpoints.

DISCUSSION:

The results of this study will provide evidence on whether nationwide implementation of PHFU for CRC in The Netherlands will be successful in reducing contact between patient and health care provider. Comparison of PROMs between in-hospital follow-up and PHFU will be provided. Moreover, the cost-effectiveness of PHFU will be assessed. TRIAL REGISTRATION Dutch Trail Register (NTR) NL9266 (Registered on January 1st, 2021).
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos